Landscape of clinically actionable mutations in breast cancer ‘A cohort study’

Breast cancer (BC) is a heterogeneous disease. Numerous chemotherapeutic agents are available for early stage or advanced/metastatic breast cancer to provide maximum benefit with minimum side effects. However, the clinical outcome of patients with the same clinical and pathological characteristics a...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Transl Oncol
Glavni autori: Ghosh, Mithua, Naik, Radheshyam, Lingaraju, Sheela Mysore, Susheela, Sridhar Papaiah, Patil, Shekar, Srinivasachar, Gopinath Kodaganur, Thungappa, Satheesh Chiradoni, Murugan, Krithika, Jayappa, Srinivas Belagutty, Bhattacharjee, Somorat, Rao, Nalini, Bandimegal, Mahesh, Krishnappa, Roopesh, Poppareddy, Shashidhara Haragadde, Raghavendrachar, Krishna Chennagiri, Shivakumar, Yogesh, Nagesh, Sunitha, Kodandapani, Ramya, Rajan, Ashwini, Bahadur, Urvashi, Agrawal, Pooja, Ramaswamy, Veena, Nanjaiah, Tejaswini Bangalore, Kunigal, Sateesh, Katragadda, Shanmukh, Manjunath, Ashwini, Ram, Amritanshu, Ajaikumar, Basavalinga S.
Format: Artigo
Jezik:Inglês
Izdano: Neoplasia Press 2020
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7581976/
https://ncbi.nlm.nih.gov/pubmed/33099186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2020.100877
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items